Buscar
Mostrando ítems 81-90 de 122
"Análisis de impacto presupuestal de la vacunación contra COVID-19 en América Latina"
(Editorial Ciencias MedicasCU, 2022)
"Objetivo. Estimar el impacto presupuestal de la vacunación contra COVID-19 en seis países de América
Latina: Argentina, Brasil, Chile, Colombia, México y Perú, durante el periodo 2021-2022.
Métodos. Se evaluaron las ...
Avaliação dos eventos adversos das vacinas aprovadas para fase 4 contra o vírus SARS-CoV-2.
(Universidade Federal de São Paulo, 2022-07-27)
Devido a pandemia causada pela doença do coronavírus de 2019 (COVID-19), foi necessário o desenvolvimento de novas vacinas com o intuito de combater a pandemia, este trabalho teve como objetivo avaliar os eventos adversos ...
Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines
(2022)
The Omicron variant of SARS-CoV-2 has been shown to evade neutralizing antibodies elicited by vaccination or infection. Despite the global spread of the Omicron variant, even among highly vaccinated populations, death rates ...
Effectiveness of an inactivated SARS-CoV-2 vaccine in children and adolescents: a large-scale observational study
(ELSEVIER, 2023)
Background Policymakers urgently need evidence to adequately balance the costs and benefits of mass vaccination against COVID-19 across all age groups, including children and adolescents. In this study, we aim to assess ...
Influence of SARS-CoV-2 mRNA Vaccine Booster among Cancer Patients on Active Treatment Previously Immunized with Inactivated versus mRNA Vaccines: A Prospective Cohort Study
(2023)
Cancer patients on chemotherapy have a lower immune response to SARS-CoV-2 vaccines. Therefore, through a prospective cohort study of patients with solid tumors receiving chemotherapy, we aimed to determine the immunogenicity ...
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
(2022)
The SARS-CoV-2 Omicron variant has challenged the control of the COVID-19 pandemic even in highly vaccinated countries. While a second booster of mRNA vaccines improved the immunity against SARS-CoV-2, the humoral and ...